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Neuron-glial antigen 2 (NG2) is a proteoglycan expressed predominantly in oligodendrocyte
progenitor cells (OPCs). NG2-expressing OPCs (NG2-OPCs) are self-renewing cells that are
widely distributed in the gray and white matter areas of the central nervous system. NG2-
OPCs can mature into premyelinating oligodendrocytes and myelinating oligodendroglia
which serve as the primary source of myelin in the brain. This review characterizes NG2-
OPCs in brain structure and function, conceptualizes the role of NG2-OPCs in brain regions
associated with negative reinforcement and relapse to drug seeking and discusses how
NG2-OPCs are regulated by neuromodulators linked to motivational withdrawal. We hope
to provide the readers with an overview of the role of NG2-OPCs in brain structure and
function in the context of negative affect state in substance abuse disorders and to integrate
our current understanding of the physiological signiﬁcance of the NG2-OPCs in the adult
brain.
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INTRODUCTION
For centuries, the cellular composition of the healthy, intact mam-
malian brain was thought to be maintained in a static state, in
the absence of cellular turnover. The relatively recent discov-
ery of neural stem cells in all mammalian species, including
humans, has forced researchers to adapt their understanding of
the basal cortical structure and function under physiologic and
pathologic conditions within the framework of this novel cellu-
lar phenomenon (Eriksson et al., 1998; Curtis et al., 2007). Nearly
every major disorder which perturbs typical functioning of the
brain, including addiction to illicit drugs, has been shown to
inﬂuence or be inﬂuenced by rates of neural stem cell prolifer-
ation, differentiation, and/or survival (Canales, 2010; Mandyam
and Koob, 2012; Drew et al., 2013). While much focus has cen-
tered on the role of generation of new neurons, or neurogenesis, it
is critical also to evaluate the role of generation of new glia, or gli-
ogenesis in typical and atypical cortical function. This review aims
to highlight the role of a particular glial cell type, the neuron-glial
2 (NG2) cell in the adult mammalian cortex and speculate on the
potential role of this specialized cell type in addiction to drugs of
abuse.
CHARACTERIZATION OF NG2 CELLS IN THE ADULT
MAMMALIAN BRAIN
NG2-GLIA: WHAT’S IN A NAME?
Glia in the brain aremainly classiﬁed into three subtypes: astroglia,
microglia, and oligodendroglia. A fourth kind of proliferative
glial cells termed NG2 cells that express their namesake charac-
teristic marker, chondroitin sulfate proteoglycan, are found to
be widely distributed throughout the gray and white matter of
the adult rodent brain (Dawson et al., 2000, 2003; Levine et al.,
2001). The notion that NG2 cells are oligodendrocyte progenitor
cells (OPCs) was conﬁrmed with in vitro studies demonstrating
that NG2 labeled cells differentiated into oligodendrocytes in a
differentiating culture preparation (Stallcup and Beasley, 1987);
thus, these NG2 cells have been referred to as NG2-OPCs. Other
names have been suggested for the NG2 cells, such as polyden-
drocytes to describe their multiple projections (Nishiyama et al.,
2002), and synantocytes to describe their contact with neurons
and astroglia (Butt et al., 2002). An in depth review on the biol-
ogy and function of NG2 cells has been published elsewhere (Hill
and Nishiyama, 2014; Tomassy and Fossati, 2014) and the cur-
rent review will brieﬂy discuss the phenotypic fate of NG2 cells
and their role in the mammalian brain in the context of addictive
disorders.
PHENOTYPIC FATE OF NG2-GLIA
Following the initial identiﬁcation of NG2 cells, one line of investi-
gation pursued the phenotypic fate of these unique cells. NG2 cells
isolated by immunopanning for A2B5 (an antibody that tags the
ganglioside moiety expressed in pre-oligodendrocytes) revealed
that NG2 cells in vitro mature into A2B5+ pre-oligodendrocytes
(Abney et al., 1983; Baracskay et al., 2007), conﬁrming that NG2
cells are directed into an oligodendrocyte phenotype. Ex vivo stud-
ies demonstrate that NG2 cells express two distinct markers of
early oligodendroglial lineage, namely, platelet-derived growth
factor α receptor (PDGFαR) and O-antigen 4 (O4), further sup-
porting thatNG2-cells are directed into anoligodendrocyte lineage
in the adult brain (Reynolds and Hardy, 1997; Nishiyama et al.,
1999; Dawson et al., 2003). Additional support for the differenti-
ation of NG2-cells into oligodendrocyte phenotype comes from
various genetic models and such studies conﬁrm the direction of
NG2 cells into oligodendrocytes and premyelinating oligodendro-
cytes in vivo. For example, using the NG2-CreERT2 transgenic
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line, it has been recently demonstrated that a large proportion of
NG2 cells in various regions of the brain express oligodendroglial
markers Olig2, Sox10 and adenomatous polyposis coli CC1 at
various stages of development; embryonic brain [(E)17.5], post-
natal brain (P3-P4), adolescent brain (P30-P34) and aged brain
[10 month old; (Huang et al., 2014)]. Taken together, it is evi-
dent that NG2 cells are capable of generating oligodendrocytes all
through the life-span of rodents.
Beyond NG2 cells developing into oligodendrocytes, several
studies suggest that NG2 cells aremulitpotent cells that are capable
of generatingneuronal progenitor cells in addition tooligodendro-
cytes. For example, 50%of glioblastoma cells isolated fromhuman
subjects were co-labeled with NG2 and nestin, a marker expressed
by neuronal progenitors (Svendsen et al., 2011). The ex vivo evi-
dence is further supported by in vivo ﬁndings, where a signiﬁcant
proportion of NG2 cells expressed GFP in the transgenic nestin-
GFP reporter mice (Ehninger et al., 2011). Furthermore, using
transgenic lines Plp-CreERT2 and PDGFRα-CreERT2, postnatal
NG2 cells were found to generate new neurons in the piriform
cortex, albeit signiﬁcantly lower in number when compared with
oligodendrocytes (Doerﬂinger et al., 2003; Rivers et al., 2008; Guo
et al., 2009). Taken together, these ﬁndings suggest that a small
proportion of NG2 cells may have the capacity to generate neural
progenitor cells and neurons in the adult brain.
While there is consistent evidence that small populations of
NG2 cells can develop into neurons during adulthood, controversy
remains over whether NG2 cells can similarly generate neurons
during development. For example, using transgenic lines NG2-
Cre and CreER BAC transgenic mice, it was demonstrated that
embryonic NG2 cells did not mediate neurogenesis (Zhu et al.,
2008b, 2011). These discrepancies in the neuronal phenotype of
NG2 cells may be attributable either to variability in cell-speciﬁc
expression of transgene due to non-homologous recombination
strategies or to the developmental proﬁle of NG2 cells in the
central nervous system (Nishiyama et al., 2009, Richardson et al.,
2011). To this end, a recent study attempted to overcome one
limitation by using NG2-CreERT2 transgenic line using homol-
ogous recombination, thus enabling the transgene to be under
the regulatory control of the endogenous regulators of the NG2
locus (Huang et al., 2014). In this study, inducing Cre activity in
NG2 cells in the second postnatal week (P14) resulted in reporter
gene colocalizing with neuronal markers such as NeuN and Tuj1
in the ventral cortex, suggesting that NG2 cells can differenti-
ate into neurons in this brain region. Interestingly, inducing Cre
activity during young adulthood (P30), did not reveal colocal-
ization with neuronal markers in the previously demonstrated
ventral cortex or regions of established adult neurogenesis (the
hippocampal dentate gyrus and subventricular zone). Instead,
the reporter-positive cells in the non-neurogenic regions in the
adult brain (ventral cerebral cortex andhippocampalCA3 regions)
were found to co-express neuronal markers NeuN and HuC/D.
Given that NG2 cells generated adult born neurons in the non-
neurogenic regions in the adult brain demonstrated morphology
of interneurons and normal electrophysiological properties, it
is tempting to speculate that NG2 cells indeed have neurogenic
potential, but to a limited capacity and with brain region speci-
ﬁcity compared with their more proliﬁc oligodendrocyte potential
(Huang et al., 2014). Alternatively, the NG2 cells with neuro-
genic potential may be a different population compared with
the NG2 cells that differentiate into oligodendrocytes, and future
studies are needed to conﬁrm the multipotency of the NG2 cell
population.
With respect to NG2 cells generating astroglial cells and
microglial cells, there is evidence to both support and to reject
the supposition. For example, the in vitro ﬁnding that NG2 cells
differentiate into type-2 astrocyte led to the conceptualization
of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells; this
was, however, considered to be an in vitro artifact based on ex vivo
and in vivo ﬁndings (Raff et al., 1983, Espinosa de los Monteros
et al., 1993, Nishiyama et al., 2009). Ex vivo studies show that there
is little or no evidence for co-labeling of astroglial speciﬁc mark-
ers [glial ﬁbrillary acidic protein (GFAP)] and microglial speciﬁc
markers OX-42 with NG2, however, the NG2 cells were reported
in close apposition with astrocytes and microglia creating points
of apparent overlap (Dawson et al., 2003, Mandyam et al., 2007).
In vivo studies using transgenic mice have also been equivocal
about the astroglial lineage of NG2 cells. Studies using the NG2-
Cre and CreER BAC transgenic mice revealed that 40% of the
protoplasmic astrocytes in the gray matter were generated from
NG2 cells. In contrast, the radial glial cells in the gray matter
and all the astroglial cells in the white matter were shown to
arise from a non-NG2 lineage (Zhu et al., 2008a,b, 2011). Fur-
thermore, in the Plp-CreERT2 transgenic mice, postnatal NG2
cells were found to generate astroglia in the ventral gray mat-
ter (Doerﬂinger et al., 2003; Guo et al., 2009). Additionally, using
NG2-CreERT2 mice, NG2-CreER BAC transgenic lines as well
as PDGFRα-CreER PAC and PDGFRα-CreERT2 BAC transgenic
lines, no evidence was found to suggest that NG2 cells in mice
(age ranging from P8 to adulthood) were capable of generat-
ing new astroglia (Rivers et al., 2008; Kang et al., 2010; Huang
et al., 2014). Taken together, it appears that the astrogenic poten-
tial of NG2 cells may be restricted to certain brain regions and
certain developmental periods; therefore more work is needed
to conﬁrm the astrogenic potential of NG2 cells in the adult
brain.
From the evidence presented, it is clear that NG2-glia have the
potential to develop into both neurons and astrocytes in adult ani-
mals, but develop primarily into oligodendrocytes; therefore, NG2
cells with oligodendrocyte potential will be the developmental lin-
eage of focus for the remainder of the review and these cells will
henceforth be called NG2-OPCs.
ROLE OF NG2-OPCs IN THE ADULT MAMMALIAN BRAIN
Beyond the phenotypic fate of NG2-OPCs, it is critical to under-
stand the role of NG2-OPCs in typical cortical function. While
neurons are thought to be the most prominent postmitotic cells in
the brain that are uniquely capable of generating action poten-
tials as a means of communicating with other cell types and
maintaining plasticity, this notion has been challenged by studies
showing that NG2-OPCs exhibit several neuron-like properties.
For example, NG2-OPCs juxtapose with pre- and post-synaptic
neurons, and share direct synaptic connections with glutamatergic
neurons, suggesting a potentially signiﬁcant contribution to ongo-
ing brain plasticity (Ong and Levine, 1999; Bergles et al., 2000;
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Paukert and Bergles, 2006). NG2-OPCs express glutamatergic
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptors and regulate extrasynaptic glutamate, suggesting that
these cells may be involved in glutamatergic signaling (Dawson
et al., 2003; Stegmuller et al., 2003; Karram et al., 2005; Paukert
and Bergles, 2006). Even more interesting was the ﬁnding that
some (but not all) NG2 cells, in both the gray and white matter
regions of the brain, are capable of generating action potentials
(Chittajallu et al., 2004; Ge et al., 2006; Karadottir et al., 2008)
and display activity-dependent cellular plasticity (Ge et al., 2006).
Therefore, it can be hypothesized that there are two distinct
populations of NG2-glia based on the expression of (or lack
of expression of) voltage-gated Na+ channels and formation of
glutamatergic synapses; alternatively, expression of voltage-gated
Na+ channels and the associated cellular characteristics are typ-
ical of a few but not all stages of maturation of NG2-OPCs.
Another open–ended question is whether the two populations of
NG2-OPCs, if present, are functionally distinct, or have distinct
capacities for differentiating into oligodendrocytes. It is tempt-
ing to speculate that the NG2-glia expressing voltage-gated Na+
channels are either terminally differentiated or are designated to a
neuronal fate, and hence are not capable of generating oligoden-
drocytes in vivo. Recent studies using NG2-reporter transgenic
mice have empirically evaluated these questions (De Biase et al.,
2010). The study demonstrated that NG2-OPCs received synap-
tic inputs from glutamatergic neurons during early postnatal
development. However, all NG2-OPCs did not respond similarly
to the glutamatergic inputs, where some NG2-OPCs exhibited
depolarization but none generated action potential. Furthermore,
differentiation of NG2-OPCs into oligodendrocytes resulted in
downregulation of both voltage-gated Na+ channels and gluta-
matergic receptors (De Biase et al., 2010). These ﬁndings suggest
that NG2-OPCs have distinct physiological roles during devel-
opment and during adulthood. Thus, these studies conﬁrm
that NG2-OPCs can contribute signiﬁcantly to ongoing synap-
tic plasticity, predominantly during the critical stages of neural
development.
Neuron-glial antigen 2 is the hallmark protein of the NG2-
OPCs and is expressed in the cell body as well as the processes
radiating from the soma (Dawson et al., 2003). Several physiologi-
cal roles have been suggested for the NG2-OPCs. For example, the
proteoglycan shares structural features with neural cell adhesion
molecules, and mediates the physical and synaptic connections
between NG2 cell processes and the cell membrane of pre- and
post-synaptic neurons (Bergles et al., 2000; Stegmuller et al., 2003).
NG2-OPCs function as precursors to oligodendrocytes and closely
interact with axons in various brain regions including the cor-
pus callosum, cortex, and hippocampus [further reviewed in
section role of NG2-OPCs in addiction; (Kukley et al., 2007;
Ziskin et al., 2007; Karadottir et al., 2008; Ge et al., 2009; Etxeberria
et al., 2010)]. Electrophysiological studies revealed glutamatergic
synapses transmitting AMPA receptor-mediated currents between
axons and NG2-OPCs, indicating functional synapses (Ziskin
et al., 2007; Etxeberria et al., 2010). Furthermore, it has been
demonstrated that the NG2-axon synapses could help to promote
growth andmyelination after nerve injury (Yang et al., 2006). Such
studies allow us to speculate that the NG2-OPC – axon synapses
may convey or receive information about the microenvironment,
which could assist with triggering trophic signaling pathways that
can aid in proliferation and differentiation of NG2-OPCs. Never-
theless, it can be hypothesized that the NG2-OPC – axon synapses
allow for quick responses to injury, particularly those requiring
remyelination processes.
Indeed, NG2-OPCs respond to axon injury by increasing their
capacity to proliferate and differentiate intomyelinating oligoden-
drocytes (Ong and Levine, 1999; Chida et al., 2011; Xiong et al.,
2013). Such responses have been demonstrated in multiple types
of demyelinating models of axon injury including hypothermia
(Xiong et al., 2013), kainate (Ong and Levine, 1999), ischemia
(Chida et al., 2011), and cuprizone (Kumar et al., 2007), where
NG2-OPC density was enhanced at the site of injury concur-
rently with increased expression of myelin basic protein (MBP;
a marker for myelinating oligodendrocytes). Notably, the NG2-
OPC response to demyelinating lesions has been associated with
up regulation of the trophic factor brain-derived neurotrophic
factor (BDNF; VonDran et al., 2011), suggesting a cell-intrinsic
type mechanism. These results demonstrate a functional role of
NG2-OPC up regulation in maintaining myelin plasticity in the
adult brain (Patel et al., 2010; Chida et al., 2011; Xiong et al.,
2013).
DEVELOPMENTAL STAGES OF NG2-OPCs IN THE ADULT
MAMMALIAN BRAIN
PROLIFERATION OF NG2-OPCs
Neuron-glial antigen 2-OPCs are predominantly found in the cor-
pus callosum and in the gray matter regions of the brain (Ong
and Levine, 1999), where they continue to proliferate during
adulthood. Experiments using mitotic markers of cellular pro-
liferation such as 5-bromo-2′-deoxyuridine (BrdU) in mice have
shown that the cell cycle dynamics of NG2-OPCs are affected
by age (Figure 1). Cell cycle time increases with age, where
NG2-OPCs cycle through one cell cycle of ∼70 days beyond post-
natal day (P)240 compared with a cell cycle length of 2 days at
P6 (Psachoulia et al., 2009). These changes in cell cycle dynamics
could support the decline in density of NG2-OPCs to approx-
imately 75% of the initial cell mass in older animal subjects
compared with newborn and young adults (He et al., 2009). These
studies allow us to hypothesize that the cell cycle dynamics (such
as length of time a cell spends in the cell cycle) of NG2-OPCs dur-
ing development regulates the differentiation of the cell, such that
reducing the length of the cell cycle assists withmaintenance of the
undifferentiated state (Lange et al., 2009; Salomoni and Calegari,
2010).
FIGURE 1 | Cell cycle time for NG2-OPCs in the rodent brain at
different postnatal (P) ages.The cell cycle has been found to slow down
with age, and this effect has been reported in the cortex as well as corpus
callosum (Psachoulia et al., 2009; Simon et al., 2011). Age in days
post-partum; cell cycle time in days (d).
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DIFFERENTIATION OF NG2-OPCs
Neuron-glial antigen 2-OPCs in the adult brain primarily dif-
ferentiate into premyelinating oligodendrocytes and myelinating
oligodendrocytes, which producemyelin tomaintain whitematter
tracts (Figure 2; Dimou et al., 2008; Rivers et al., 2008; Zhu et al.,
2008a,b, 2011; Geha et al., 2010; Kang et al., 2010; Clarke et al.,
2012). The oligodendrocyte lineage of NG2 cells is dependent
upon expression of basic helix-loop-helix transcription factors
OLIG1 and OLIG2 (Zhu et al., 2012). For example, Zhu et al.
(2012) used conditional knockout mice to cause constitutive
and inducible deletions of Olig2 speciﬁcally in NG2 cells to
show that when Olig2 is knocked down, NG2 cell fate switch to
astrocytes rather than oligodendrocytes (Zhu et al., 2010). Such
loss-of-function genetic studies conﬁrm the importance of OLIG2
expression in directing the NG2-OPCs to a myelinating oligo-
dendrocyte lineage. Recent research supports the generation of
myelinating oligodendrocytes from the proliferating pool of NG2-
OPCsduring adulthood, and these cells eventually expressmarkers
associated with myelin, such as myelin basic protein (Rivers
et al., 2008; Geha et al., 2010; Clarke et al., 2012). However, the
functional signiﬁcance of adult-generated myelinating oligoden-
drocytes remains to be explained. Below we will brieﬂy discuss an
important marker that is key to the process of differentiation of
NG2-OPCs into myelinating oligodendrocytes.
OLIG1 and OLIG2
Oligodendrocyte transcription factor 1 and 2 (OLIG1 andOLIG2)
are transcription factors that are predominantly expressed in
OPCs and in myelinating oligodendrocytes (Takebayashi et al.,
2000; Zhou et al., 2000). Structurally, these transcription factors
dimerize at the basic helix-loop-helix region and bind to their
DNA targets to regulate transcription of other genes associated
with ongoing biological functions such as neurogenesis and reac-
tive gliogenesis (Fancy et al., 2004; Buffo et al., 2005; Menn et al.,
2006). Detailed descriptions of the structural and functional dif-
ferences between OLIG1 and OLIG2 have been recently published
elsewhere and the readers are referred to the review by Meijer
et al. (2012). Brieﬂy, OLIG1 regulates the expression of several
genes involved in oligodendroglial maturation, including MBP,
myelin oligodendrocytic glycoprotein, myelin proteolipid protein,
and zinc ﬁnger protein 488 (Arnett et al., 2004; Xin et al., 2005;
Wang et al., 2006; Guo et al., 2010). Additionally, OLIG2 has been
found to play several critical roles in oligodendrocyte differen-
tiation including enhancing the expression of Sox10 and Sip 1,
proteins that enhance oligodendrogial activity and maturation of
NG2-OPCs (Wang et al., 2006; Kuspert et al., 2011; Weng et al.,
2012; Yu et al., 2013). However, OLIG2 also has been identiﬁed
as a transcription repressor for several targets and consequently
has been implicated in human glioma (Lee et al., 2005; Ligon et al.,
2007;Mehta et al., 2011). For example, OLIG2 is also implicated in
modulating the response of non-oligodendrocytic glial cells, such
as in reactive gliogenesis (proliferationof astrocytes andmicroglia)
following a demyelinating injury in the cortex (Arnett et al., 2004;
Chen et al., 2008b). These ﬁndings are in apparent contradiction
to studies that reveal an absence of lineage relationship between
OLIG 1/2 expressing cells and astrocytes, as well as studies showing
that NG2-OPCs are not progenitors of reactive astroglia (Dimou
et al., 2008; Komitova et al., 2011). These contradictions may be
explained by the transient, non-lineage-dependent expression pat-
tern of OLIG2 in the reactive astroglia (Magnus et al., 2007; Zhao
et al., 2009).
ROLE OF NG2-OPCs IN ADDICTION
Addiction to illicit drugs has taken emotional and ﬁnancial tolls
on society, cutting across ages, races, ethnicities, and genders.
Eventual dependence on any illicit drug increases mortality, mor-
bidity, and economic costs. Despite the increase in the prevalence
of addiction to illicit substances and the market for novel thera-
peutics, the research into understanding the neurobiological basis
of addiction and relapse has progressed less well. Broadly deﬁned,
addiction is one of the many disorders that involves impulsiv-
ity and compulsivity (Heilig and Koob, 2007; Koob and Volkow,
2010), inwhich the impulsive phase involves the pleasurable effects
of the drug andupon abstinence produces reward-induced craving
FIGURE 2 | (A) Coronal section of the adult rat brain through the mPFC; the
mPFC is shaded in peach. Proliferating cells in the mPFC differentiate into
oligodendrocyte progenitor cells (OPC) and premyelinating oligodendrocytes.
(B) Developmental stages of oligodendrocyte progenitors in the mPFC;
proteins and transcription factors that are expressed in distinct stages are
indicated below.
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and the compulsive phase develops after prolonged use of the
drug when the individual seeks avoidance of the negative effects
associated with drug withdrawal. The impulsive and compul-
sive phases of addiction can be characterized into three stages:
(1) binge/prolonged intoxication, (2) withdrawal neutral/negative
affect, and (3) preoccupation/anticipation (craving). The last
stage of the addiction cycle describes a key element of relapse
in humans and therefore deﬁnes addiction as a chronic relapsing
disorder. Relapse to drug-seeking behavior is one of the least stud-
ied aspects of addiction, which has been a challenging area for
neuroscientists.
Utilizing intravenous self-administrationmodels of drug expo-
sure, the research on addiction indicates dysregulation of the
‘hedonic set point’ and alteration in allostasis of the brain reward
system which underlies the relapse to drug seeking and con-
sequently addiction to the drug of abuse (Koob and Nestler,
1997; Koob and Le Moal, 2001, 2005). The relapse circuitry in
adult mammalian brain is carved out based on multiple ground-
breaking studies performed in rodent models of reinstatement
(Shaham et al., 2003). The key brain regions implicated in the
reinstatement of drug-seeking behavior include, but are not lim-
ited to, the prefrontal cortex (PFC), nucleus accumbens (NAc),
bed nucleus of the stria terminalis (BNST), amygdala, hippocam-
pus and the ventral tegmental area (VTA; Shaham et al., 2003;
Koob and Volkow, 2010). The mesocorticolimbic dopamine sys-
tem possesses neural connections from the VTA to the PFC and
NAc and was crowned as the key circuit for reward and rein-
statement of drug-seeking behaviors (Schultz, 1998; Horvitz,
2000; Robinson and Berridge, 2000; Comoli et al., 2003; Steke-
tee, 2005). Most importantly, it is believed that the release
of the neurotransmitters such as dopamine, glutamate, and
corticotrophin-releasing factor in the key brain regions associ-
ated with relapse are essential for the behavioral outcomes of
the drug (Wise, 1998; Di Chiara, 1999; Koob, 1999; Lu et al.,
2003; Knackstedt and Kalivas, 2009). Furthermore, recent evi-
dence supports the hypothesis that elevated anxiety, low mood,
and increased sensitivity to stress (collectively labeled as nega-
tive affect) is the driving force behind the transition to addiction
(George et al., 2014). Particularly interesting is the accumulat-
ing evidence that pathological neuroadaptations in the mPFC,
extended amygdala and hippocampus may contribute to the
negative affect state (Deschaux et al., 2012; George et al., 2012;Ven-
druscolo et al., 2012; Cohen et al., 2014). The following topics will
characterize the NG2-OPCs in the brain regions associated with
the negative affect state and hope to provide promising insights
into translating the science of NG2-OPCs to future novel ther-
apeutic approaches to target the relapse stage of the addiction
cycle.
CHARACTERIZATION OF NG2-OPCs IN THE PREFRONTAL CORTEX
The PFC regulates executive functions such as decision making,
impulse control and workingmemory (Bechara et al., 1994, 2001).
Decreased PFC function has been associated with addiction, such
that preexisting impairments in PFC function (as seen in atten-
tion deﬁcit hyperactivity disorder and schizophrenia) serve as
predictors for enhanced vulnerability for addiction (Crews and
Boettiger, 2009; de Wit, 2009; Groman et al., 2009; Wing et al.,
2012). Furthermore, chronic use of addictive drugs has been
shown to enhance functional deﬁcits in the PFC, particularly those
related to decision making and impulse control, as a mechanism
to perpetuate the recurrent relapsing drug-addicted phenotype
(Franklin et al., 2002; Johnson et al., 2008; Xiao et al., 2008; Crews
and Boettiger, 2009; de Wit, 2009; Koob and Volkow, 2010).
Studies have shown that within the mammalian cortex there is
an abundant NG2 cell population that forms an evenly distributed
and dense network (Figure 3; Dawson et al., 2003; Girolamo et al.,
2010), however, the explicit role of NG2-OPCs in the mammalian
cortex is still unclear. Recent studies in rodents have been directed
at determining the role of these unique cells. While functional
implications of NG2-OPCs are of critical interest, most recent
studies of such cells in the cortex, and more speciﬁcally the PFC,
are targeted at understanding proliferation and differentiation of
NG2-OPCs.
Due to the important role the PFC plays in mood disorders
such as depression, research with regard to this clinical condition
has added information to further the understanding of this issue.
Studies focusing on electroconvulsive seizure (ECS) treatment
have explored phenotypic analysis and proliferation of cells in the
PFC. Studies showed that in addition to an increase in prolifera-
tion of cells following ECS treatment, there is a larger proportion
of NG2-OPCs when compared with other cell types such as astro-
cytes, neurons, or endothelial cells.While some studies showonly a
modest increase in the number of NG2-OPCs, others demonstrate
that 40–50% of newly born cells are co-labeled as NG2 positive
cells (Madsen et al., 2005; Czeh et al., 2007; Ongur et al., 2007).
Other cell types, such as endothelial cells, were detectable but at
a much lower proportion than NG2-OPCs. Astrocytes and neu-
rons were consistently absent from such phenotypic analysis in
these ECS studies. Additional inquiry into the role of NG2-OPCs
in the cerebral cortex has revealed that stab wound injuries to
the cortex also produce a large proportion of NG2-OPCs in the
injured area, in this case as much as ﬁve times as many NG2
cells when compared to non-injured controls (Simon et al., 2011).
This evidence is very similar to the previous ﬁndings in the PFC
region.
Depression and affective disorders are not the only realmwhere
NG2 cells in the PFC play an important part. Drug abuse research
considers the PFC function to be an important factor in the
negative reinforcement associated with motivational withdrawal
and research in this ﬁeld has demonstrated increased levels of
NG2-OPCs in the PFC when animals are exposed to intermittent
exposure to powerful psychostimulants like methamphetamine
(Mandyam and Koob, 2012). Chronic exposure to metham-
phetamine or to sedative-hypnotics, such as alcohol, proves to be
too toxic for these NG2-OPCs to survive (Mandyam et al., 2007;
Richardson et al., 2009; Kim et al., 2014). Therefore, these studies
support the hypothesis that the glial disturbance observed with
chronic drug exposure may serve as an indirect mechanism to
promote neurotoxicity.
The only deviation with regards to cellular differentiation from
previously discussed studies is discovered when examining the
effect of other proliferation enhancing treatments such as physical
activity. Animals were given voluntary access to running wheels
and were examined postmortem to determine cellular phenotype
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FIGURE 3 | (A) NG2 positive (NG2+) cells are the predominant
proliferating cell type in most brain regions except in the granule cell
layer (GCL) of the hippocampus. Data derived from previous publications
(Dawson et al., 2003; Wennstrom et al., 2004; Orre et al., 2009;
Hattiangady and Shetty, 2010; Ehninger et al., 2011). (B) Survival/
persistence of NG2+ cells is low in the GCL of the hippocampus. In
contrast more than 50% of the surviving BrdU cells are NG2+ in the
hippocampal non-GCL areas, cerebral cortex and prefrontal cortex (PFC)
as well as the amygdala. Data derived from previous publications
(Wennstrom et al., 2004; Komitova et al., 2006; Czeh et al., 2007;
Mandyam et al., 2007; Orre et al., 2009; Hattiangady and Shetty, 2010;
Ehninger et al., 2011). GCL, granule cell layer; H-GCL, hippocampus
without GCL; CeC, cerebral cortex; PFC, prefrontal cortex; Amg,
amygdala; CC, corpus callosum.
in the PFC (Mandyamet al., 2007). In contrast to studies observing
the effects of harmful processes on cell differentiation in the PFC,
thewheel running data showed that newly born cells in the PFC are
still mostly labeled as NG2-OPCs, but there were higher amounts
of other kinds of cells observed such as neurons and astrocytes
than have been seen in other studies. Therefore, there may be a
relationship between the overall environment of the PFC and the
capability of cells to differentiate into different cell types. Another
study supports this hypothesis in the cerebral cortex by observing
that when voluntary physical exercise was provided to animals,
there was a reduced population of NG2-OPCs and increased levels
of premature differentiation into oligodendrocytes (Simon et al.,
2011).
Collectively, the data suggests that when there is an insult to
the brain, say for example, by depression, stab wound or drug
abuse, a large population of NG2-OPCs is needed to protect
against these harmful effects and does not allow these cells to
mature into different types of cells. Whereas if there is already a
protective mechanism in place, like exercise, NG2-OPCs are still
abundant in the PFC but allow for a wider range of maturation
within the cell population. One last piece of compelling evidence
was seen using in vivo recordings via cranial windows to observe
NG2-OPCs. Following focal laser lesions in the cortex, NG2 cells
were seen migrating to the injured sites and eventually surround-
ing the site and contributed to forming a glial scar (Hughes et al.,
2013).
In summation, studies focusing on NG2 in the cortex and
PFC have shown that NG2-OPCs are decreased along with the
entire cell population in pathology. Additionally, NG2-OPCs are
increased with treatments like pharmacological and physiologi-
cal interventions. However, exercise supported the proliferation
and differentiation into astrocytes and neurons. Taken together,
this evidence provides support that NG2-OPCs in the PFC are
involved in repair processes following insult.
CHARACTERIZATION OF NG2-OPCs IN THE HIPPOCAMPUS
The hippocampus is involved in learning and memory, cognitive
function as well as mood regulation (Li et al., 2009; Jun et al.,
2012). While the dorsal hippocampus has been implicated in
modulating declarative and contextual memory, the ventral hip-
pocampus via its reciprocal connections with the amygdala has
been implicated in regulation of mood; both of these systems
undergomaladaptive changes following chronic exposure to drugs
of abuse (White, 1996; Volkow et al., 2004; Koob and Volkow,
2010). Adult neurogenesis in the hippocampal subgranular zone
is particularly sensitive to chronic drug induced disruption lead-
ing to aberrant adaptions in memory (Canales, 2007, 2010; Jun
et al., 2012). Neuroadaptions in the hippocampus are particularly
important as they contribute to enhanced sensitivity to context
as well as stress induced relapse (Kilts et al., 2001; Crombag et al.,
2008; Koob, 2008; Koob and Volkow, 2010; Belujon and Grace,
2011).
The existence of NG2-OPCs in the hippocampus is well estab-
lished. In the normal adult,NG2-OPCs are distributed throughout
all layers of the hippocampus (Levine and Nishiyama, 1996; Ong
and Levine, 1999; Xu et al., 2014) with higher numbers in the
stratum lucidum and dentate hilus (Figure 3; Bu et al., 2001).
The functional role of NG2-OPCs in the hippocampus, however,
remains to be found. Possible functions can be discussed based on
what is known about NG2 cell development, NG2 cell interactions
with other cell types, and NG2 cell reactions to changes in the
hippocampus.
Neuron-glial antigen 2-OPCs are present and proliferate both
during development and into adulthood. The density of NG2-
OPCs in the adult hippocampus changes with age (Levine and
Nishiyama, 1996; Chen et al., 2008a, Hughes et al., 2013). Ini-
tially, the number of NG2-OPCs increased from P0–P7, and then
decreased when measured at P21, P50, and P450 as evidenced by
NG2 immunostaining and NG2 protein level expression (Chen
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et al., 2008a). NG2 cell morphology also changes with age, with
neonatal rats expressing NG2 in cells with ‘simpler’ morphol-
ogy, and ‘complex’ morphology appearing by P7. Most of the
NG2-OPCs in the adult hippocampus have a stellate morphol-
ogy with several processes radiating from the soma (Ong and
Levine, 1999; Chen et al., 2008a; Xu et al., 2014). NG2-OPCs are
motile and extend processes to survey the surrounding environ-
ment. NG2-OPCs maintain homeostatic control of cell density
through a balance of differentiation, proliferation, cell-death, and
self-repulsion (Hughes et al., 2013).
The proliferation and differentiation of NG2-OPCs in the
hippocampus has been described extensively [for review see
(Richardson et al., 2011)]. NG2 cells are considered to be
NG2-OPCs that eventually differentiate into myelinating oligo-
dendrocytes (Butt et al., 1999; Nishiyama et al., 1999, 2009;
Wigley et al., 2007; Kang et al., 2010); however, there are stud-
ies that investigated the multipotency of NG2 cells in the CNS
(Kondo and Raff, 2000; Sypecka et al., 2009). There is evi-
dence that hippocampal cell cultures provide a neuronal micro-
environment that can induce NG2-derived neurogenesis (Sypecka
et al., 2009). However, several fate-mapping studies in trans-
genic mice show that in the hippocampus, NG2-OPCs primarily
develop into myelinating oligodendrocytes (Zhu et al., 2008a,b,
2011).
The spatial organization of NG2-OPCs led researchers to inves-
tigate communication between NG2-OPCs and other cell types.
NG2-OPCs are in close contact with astrocytes and neurons
(Nishiyama et al., 1999; Ong and Levine, 1999; Xu et al., 2014).
There is now surmounting evidence of NG2-OPCsmaking synap-
tic contact with neurons [for review see (Karram et al., 2005)].
Neuron-NG2 cell synapses have been identiﬁed by electrophys-
iological techniques (Bergles et al., 2000; Lin and Bergles, 2004;
Jabs et al., 2005; Ge et al., 2006; Kukley et al., 2008; Mangin et al.,
2008). Kukley et al. (2010) used aNG2cre:Z/EG double-transgenic
mouse line to identify developmental stages of NG2-OPCs and see
at what stages they make synaptic contact with neurons in CA1
of hippocampus.Whole-cell patch clamp recordings revealed that
synaptic input is restricted toNG2-OPCs, and is lostwhen theydif-
ferentiate into premyelinating and myelinating oligodendrocytes
(Kukley et al., 2010).
AMPA receptors that are calcium permeable have been found
on hippocampal NG2-OPCs (Seifert and Steinhauser, 1995;
Bergles et al., 2000; Lin and Bergles, 2002). NG2-OPCs can
respond to neuronal stimulation and neurotransmitter release
because they harbor N-methyl-D-aspartate (NMDA) receptors,
AMPA receptors and γ-aminobutytic acid (GABA) receptor sub-
type A (GABAA; Bergles et al., 2000; Lin and Bergles, 2002, 2004;
Chittajallu et al., 2004; Jabs et al., 2005; Karadottir et al., 2005;
Salter and Fern, 2005; Ge et al., 2006; Paukert and Bergles, 2006;
Kukley et al., 2007). Neuron-NG2 synapses can have activity-
dependent changes analogous to long-term potentiation (LTP)
at glutamatergic neuronal synapses. LTP expression in neuron-
NG2 synapses is mediated by calcium-permeable AMPA receptors
located on NG2-OPCs (Ge et al., 2006).
Connections between neurons and NG2-OPCs allowNG2 cells
to be highly responsive to injuries in the hippocampus, induc-
ing different morphological and proliferative changes over time
(Nishiyama et al., 1999; Bu et al., 2001). After kainic acid-induced
excitotoxic lesions in the hippocampus, NG2-OPCs showed two
types of reactive changes: the early and persistent change 24 h
to 3 months after lesion and the late, transient change 2 weeks
after lesion (Bu et al., 2001). The ﬁrst early change was charac-
terized as an increase in NG2 immunoreactivity and an increase
in processes extending from the cell body. NG2-OPCs during
the late change had large round cell bodies, had short pro-
cesses and they also expressed OX42 and ED1, markers for
microglia/macrophages. There was also a corresponding change
in the distribution of GFAP+ astrocytes in CA3. At 3 days
post lesion, NG2 reactivity was high while GFAP cells were
low, and at 2 weeks post lesion, NG2 reactivity was reduced
while astrocytes ﬁlled in (Bu et al., 2001). Increases in NG2
reactivity is similar for multiple injury types, including inﬂam-
mation (Nishiyama et al., 1997), viral infection (Levine et al.,
1998), mechanical wound (Levine, 1994), ECSs (Jansson et al.,
2009) and excitotoxic lesion (Ong and Levine, 1999). Similar
changes in morphology and antigen expression in NG2-OPCs
occurred in parallel with activation of microglia using a model
of selective neurodegeneration in the mouse dentate gyrus with
trimethyltin (Fiedorowicz et al., 2008). The monocyte properties
of NG2-OPCs suggest that the NG2 cells may serve a function in
phagocytosis.
The response of increasing NG2-OPC proliferation can be the
ﬁrst stages of a myelination response. Lesions of the entorhino-
hippocampal perforant pathway induces formation of axonal
sprouts, which recruits NG2-OPCs to divide and become oligo-
dendrocytes as evidenced by NG2 cells and oligodendrocytes
incorporating BrdU 9 weeks post lesion (Drojdahl et al., 2010).
One way NG2-OPCs respond to the environment is through acid
chemosensors, speciﬁcally the ASIC1a channel found in the cell
membrane. Activation of these channels can induce membrane
depolarization and Ca2+, which would serve as a quick response
to injury following ischemia (Lin et al., 2010). It appears that
NG2-OPCs in the hippocampus function to maintain glial home-
ostasis. Their responses to mechanical and cellular injury suggest
that NG2-OPCs in the hippocampus may assist with maintaining
hippocampal myelin plasticity.
CHARACTERIZATION OF NG2-OPCs IN THE AMYGDALA
The amygdala is involved in modulating emotional memory and
affective behavior, and is particularly important for fear learn-
ing and adverse reactions; these behavioral maladaptations in
the amygdala are associated with negative reinforcement which
triggers relapse to drug seeking (Grant et al., 1996; Maren, 1999;
Blair et al., 2001; Kilts et al., 2001; Funk et al., 2006; Koob, 2008).
Structural abnormalities in the amygdala are associated with the
pathophysiology of addiction and several neurological disorders,
including but not limited to depression, schizophrenia and tem-
poral lobe epilepsy (Sheline et al., 1998; Mervaala et al., 2000;
Wright et al., 2000; Drevets et al., 2002; Faber-Zuschratter et al.,
2009; Chen et al., 2014). Several studies have uncovered neuronal
aspects of amygdalar plasticity (for example synaptic plasticity
and neurotropic mechanisms) in emotional behaviors [for review,
(Maren, 2005)], however few studies have evaluated gliogenesis in
amygdalar plasticity.
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Amygdalar NG2 cells share several similarities with NG2-
OPCs in the cortex and hippocampus. Approximately, 88–94%
of the proliferating cells in the adult rodent amygdala were
NG2-OPCs (Figure 3), and this pool of NG2 cells appear
to exhibit limited differentiation over time (Wennstrom et al.,
2004; Ehninger et al., 2011). These cells exhibit electrophysi-
ological properties that were similar to the NG2-OPCs from
corpus callosum (Ehninger et al., 2011). Similar to hippocampus
and PFC, ECSs [established therapeutic strategy for depres-
sion (Clarke et al., 1989)], increased proliferation of NG2-OPCs
(NG2+/BrdU+), increased expression of NG2 protein (Jans-
son et al., 2009), and subsequent differentiation into mature
oligodendrocytes 3 weeks after cell division (RIP:oligodendrocyte
marker and BrdU+) in the amygdala (Wennstrom et al., 2004;
Jansson et al., 2009). Furthermore, oral administration of
lithium chloride (established treatment for bipolar disorder)
was reported to increase proliferation of NG2-OPCs in the
amygdala (a similar response compared with the hippocam-
pus and PFC), but enhanced proliferation was not associated
with an increase in differentiation of NG2 cells into mature
oligodendrocytes (Orre et al., 2009). However, physical activ-
ity via wheel running and environmental enrichment in rats
did not alter the proliferation or the survival of newly born
NG2-OPCs in the amygdala (an opposite response compared
with the hippocampus and PFC), but decreased formation of
new astroglia (S100β: astroglial marker and BrdU+) in the
amygdala (Ehninger et al., 2011). The differences in responses
to the wheel running stimulus could be due to variability in
experimental design as the study in the amygdala used control
rats that were not maintained under impoverished environ-
mental conditions [for description impoverished environment,
(Bardo et al., 1997)]. Taken together, research thus far sug-
gests that amygdalar NG2-OPCs proliferation is a neuroplastic
response restricted to certain pharmacological or mechanical type
injuries.
In the above context, amygdalar gliosis and aberrant NG2
cell expression is associated with temporal lobe epilepsy (Faber-
Zuschratter et al., 2009). Structural abnormalities in the amygdala
are associated with the pathophysiology of mood disorders like
depression (Sheline et al., 1998; Mervaala et al., 2000; Drevets
et al., 2002) and of psychiatric disorders such as schizophrenia
(Wright et al., 2000; Chen et al., 2014). In fact, postmortem studies
suggest that schizophrenia patients exhibit decreased oligodendro-
cyte density in the amygdala compared with age-matched controls
(Uranova et al., 2004; Williams et al., 2013). It appears that much
more data is available in the amygdala to demonstrate that NG2
glial disturbance occurs in response to mood disorders and neu-
rodegenerative diseases. However, further studies are required to
uncover the role of NG2-OPCs in the amygdala in addiction and
relapse to drug seeking.
NEUROMODULATORS OF STRESS RESPONSES AFFECT NG2-OPCs
Addiction and eventual dependence to illicit drugs and alco-
hol induces attenuated (opposing) basal stress hormone lev-
els [adrenocorticotropic hormone (ACTH) and corticosterone
(CORT) an agonist at the glucocorticoid receptor (GR) and the
mineralocorticoid receptor (MR)] compared with non-dependent
subjects (enhanced stress hormone levels), and it has been
demonstrated that the blunted stress response is a consequence of
chronic drug or alcohol exposure (Zorrilla et al., 2001; Mandyam
et al., 2008; Richardson et al., 2008). Importantly, the ﬁnd-
ings from the animal studies are consistent with clinical stud-
ies that link maladaptive hypothalamic-pituitary-adrenal (HPA)
axis function with drug dependence and alcoholism, including
a reduced ability to cope with stress and negative correla-
tions between cortisol and craving and relapse in dependent
subjects (Lovallo et al., 2000; Winhusen and Somoza, 2001;
O’Malley et al., 2002; Nava et al., 2006). Although the pre-
cise mechanism underlying the attenuated stress response is
unknown, several studies have implicated activation of pro-stress
hormones [via enhanced expression of corticotrophin releas-
ing factor (CRF) and altered expression of the CRF receptors]
in the extended amygdala to contribute to the dysregulated
stress system associated with dependence (Wand, 2005; Koob,
2008). Furthermore, enhanced GR levels in the extended amyg-
dala during protracted abstinence has been demonstrated in
dependent animals and such associated changes in GR system
could play a mechanistic role in sensitivity to stress/reward and
relapse associated with dependence (Vendruscolo et al., 2012).
However, the functional signiﬁcance of altered GR system
in mediating blunted stress responses in drug dependence is
unknown.
The few select studies that have attempted to ascertain a rela-
tionship between stress and NG2-OPCs have established a role
for CORT in the proliferation, differentiation, and generation of
myelin of these developmentally derived cells that appears to be
dose and duration dependent (Chari, 2014). Oligodendroglia are
sensitive to activation of the HPA axis and subsequent release of
stress hormones as they expressMRs andGRs (Jenkins et al., 2014).
Prolonged exposure to glucocorticoids suppresses NG2-OPC pro-
liferation, and synthetic glucocorticoids inhibit oligodendrocyte
death. Stress hormones, or their analogs, can have protective
effects when the exposure is acute. For example, treatment with
methylprednisolone, a GR agonist, resulted in typical rates of cell
death of cells expressing neuronal markers but preferential sur-
vival of cells expressing oligodendrocytemarkers (Lee et al., 2008).
Similarly, exposure to physiological (physical restraint) or phar-
macological (CORT injection) stress resulted in a skewed ratio
of neuron to glia in terms of neurogenic development (Chetty
et al., 2014). For example, while under typical conditions, the
newly born cells in the subgranular zone of the hippocampus
develop primarily into neurons but following stress exposure
and stress hormone exposure, there was a signiﬁcant increase
in the number of oligodendrocytes and a reduced number of
neurons (Chetty et al., 2014). Additionally, exposure to dexam-
ethasone on oligodendrocytes in culture results in increased rates
of myelin formation and a subsequent increase in the overall quan-
tity of myelin (Chan et al., 1998). However, excessive exposure to
CORT has been shown to suppress proliferation of NG2-OPCs
(Alonso, 2000; Wennstrom et al., 2006) and this effect does not
appear to be age dependent, as decreases in both MBP expres-
sion and the number of oligodendrocytes are reported in fetal
animals subjected to a GR agonist, betamethasone (Kumar et al.,
2007).
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These ﬁndings are of further importance as they shed light into
the cellular pathologyof humandepression andaffective disorders.
Studies of chronically depressed human subjects have reported sig-
niﬁcant reductions in the number of glia in frontal cortical areas
(Ongur et al., 1998; Rajkowska et al., 1999; Uranova et al., 2004;
Rajkowska and Miguel-Hidalgo, 2007), ﬁndings which are par-
alleled in animal models of chronic stress. Rodents which were
subject to chronic social defeat, a model of chronic stress (Rygula
et al., 2005, 2006a,b; Krishnan et al., 2008), had a signiﬁcantly
depressed rate of cell proliferation in the mPFC, however, the
percentage of the proliferating cells which were NG2-OPCs was
comparable to non-stressed controls (Czeh et al., 2007). As human
patients diagnosed with chronic depression are reported to have
dysfunction of the HPA axis resulting in systemically elevated
CORT levels (Stokes, 1995; Pariante and Miller, 2001; Burke et al.,
2005; Cieslik et al., 2007), the reduced number of NG2-OPCs in
these patients corresponds to the preclinical ﬁndings with chronic
stress or artiﬁcial stress hormone administration. Further sup-
porting this damaging relationship of stress hormones and NG2
proliferation is the work with antidepressant therapies, both phar-
macological (i.e., ﬂuoxetine) and physical (i.e, electroconvulsive
therapy), which produced measureable increases in the number
of NG2-OPCs (Kodama et al., 2004; Wennstrom et al., 2004; Czeh
et al., 2007). Taken together, there is a clear link between exposure
to chronic stress hormones and the dysregulation of NG2-glia
proliferation and differentiation.
Oligodendroglia express dopaminergic receptors, and their
activation can drive and inﬂuence development of premyelinat-
ing oligodendrocytes and myelin; the activation of D2 and D3
receptors on oligodendrocytes following oxidative stress injury
can reduce glial loss. For example, NG2-OPCs have been shown to
express dopamine receptors, speciﬁcally the D3 receptor (Bongar-
zone et al., 1998), and there is evidence that analogs of these glial
precursors in human embryonic stem cell cultures express sero-
tonergic receptors (5HT2A; Schaumburg et al., 2008). However,
there has been no clear establishment of the function of dopamine
or serotonergic receptors in NG2-OPCs with regard to disease
pathology. However, a link has been established associating the
diagnosis of mood disorders and NG2 proliferation, and while a
likely biochemical mediator of these effects is the dysregulation of
the monoamiergic system, it is not clear in which order the events
occur; does deleterious behavior precede biochemistry implying
NG2 proliferation as a pathologic response, or does a change in
cortical function at a cellular level lead to pathological cortical
function, implying that NG2 dysfunction is potentially driving
the disease state? Future studies directed at speciﬁcally answer-
ing this question, as well as the precise involvement and function
of monoaminergic receptors will be required to elucidate these
processes.
CONCLUDING THOUGHTS
In conclusion, there is substantial evidence that NG2-OPCs cells
are critical for homeostatic control of oligodendrocytes in the adult
brain. There is also evidence demonstrating that under patho-
logic conditions, NG2-OPCs can play a role in potential repair
processes. Similarly, further studies are required in the future
to conﬁrm the neurogenic potential of NG2-OPCs particularly
during adulthood, ﬁndings which could aid in the understand-
ing of the role in NG2-OPCs in addiction. The prospective role
of NG2-OPCs in the cortical pathology associated with drug
addiction is a promising and underexplored area of research for
investigating both pathophysiological mechanisms and potential
strategies for recovery. NG2-OPCs are therefore a novel cell type
requiring critical investigation into their function and role in the
mammalian cortex.
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